Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C112765 |
17-(allylamino)-17-demethoxygeldanamycin |
17-(allylamino)-17-demethoxygeldanamycin results in decreased expression of KIT protein | decreases expression | 16213582
|
C112765 |
17-(allylamino)-17-demethoxygeldanamycin |
17-(allylamino)-17-demethoxygeldanamycin results in increased degradation of and results in decreased expression of KIT protein | decreases expression|increases degradation | 16061882
|
C054919 |
2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene |
[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of KIT mRNA | affects cotreatment|increases expression | 19422813
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [KIT protein polymorphism results in increased expression of HMOX1 protein] | decreases reaction|increases expression | 17420286
|
C011269 |
2,5-hexanedione |
2,5-hexanedione results in decreased expression of KIT protein | decreases expression | 17725299
|
C011269 |
2,5-hexanedione |
resveratrol inhibits the reaction [2,5-hexanedione results in decreased expression of KIT protein] | decreases expression|decreases reaction | 17725299
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of KIT mRNA | increases expression | 16788091
|
D000082 |
Acetaminophen |
Acetaminophen results in increased expression of KIT mRNA | increases expression | 18467506
|
D000082 |
Acetaminophen |
Acetaminophen results in increased expression of KIT protein | increases expression | 18467506
|
D000452 |
Aldrin |
[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of KIT mRNA | affects cotreatment|increases expression | 19422813
|
C040534 |
alpha-hexachlorocyclohexane |
alpha-hexachlorocyclohexane results in increased expression of KIT mRNA | increases expression | 16940010
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of KIT mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic results in decreased expression of KIT mRNA | decreases expression | 19654921
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of KIT protein modified form | decreases expression | 19619438
|
C472777 |
bisperoxovanadium |
bisperoxovanadium results in increased expression of KIT protein | increases expression | 17601985
|
C461979 |
CT52923 |
CT52923 binds to and results in decreased activity of KIT protein | affects binding|decreases activity | 15994924
|
D003632 |
Dichlorodiphenyldichloroethane |
[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of KIT mRNA | affects cotreatment|increases expression | 19422813
|
D003633 |
Dichlorodiphenyl Dichloroethylene |
[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of KIT mRNA | affects cotreatment|increases expression | 19422813
|
D004026 |
Dieldrin |
[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of KIT mRNA | affects cotreatment|increases expression | 19422813
|
D004958 |
Estradiol |
Estradiol affects the expression of KIT mRNA | affects expression | 15598610
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of KIT mRNA | increases expression | 17942748
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of KIT exon | increases mutagenesis | 15731517
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of KIT gene | increases mutagenesis | 15820307
|
D015073 |
2-Acetylaminofluorene |
2-Acetylaminofluorene results in increased expression of KIT protein | increases expression | 15133858
|
C097613 |
imatinib |
imatinib inhibits the reaction [KIT protein results in increased expression of HMOX1 protein] | decreases reaction|increases expression | 17420286
|
C097613 |
imatinib |
imatinib results in decreased activity of KIT protein | decreases activity | 16940797 21471107
|
D007501 |
Iron |
Iron deficiency results in decreased expression of KIT mRNA | decreases expression | 20368581
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of KIT mRNA | increases expression | 12634122
|
C121565 |
pifithrin |
pifithrin results in decreased expression of KIT mRNA | decreases expression | 19098008
|
C411007 |
PKC412 |
PKC412 inhibits the reaction [KIT protein polymorphism results in increased expression of HMOX1 protein] | decreases reaction|increases expression | 17420286
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [2,5-hexanedione results in decreased expression of KIT protein] | decreases expression|decreases reaction | 17725299
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of KIT mRNA | increases expression | 12016162
|
C116890 |
SU 5416 |
SU 5416 results in decreased activity of KIT protein | decreases activity | 12673719 12649163
|
C412603 |
SU 6668 |
SU 6668 results in decreased phosphorylation of and results in decreased activity of KIT protein | decreases activity|decreases phosphorylation | 16144927
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of KIT mRNA | increases expression | 16102516
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of KIT mRNA | increases expression | 16788091
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of KIT mRNA | increases expression | 17303670
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of KIT mRNA | increases expression | 19101580
|
C025643 |
vinclozolin |
vinclozolin affects the expression of KIT mRNA | affects expression | 19015723
|
D014807 |
Vitamin D |
Vitamin D affects the expression of KIT mRNA | affects expression | 20368581
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D015746 |
Abdominal Pain |
|
SU 5416 |
6.86 | 12673719 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.19 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
7.19 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
imatinib |
9.51 | 18322153 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
9.51 | 19490988 |
MESH:D000022 |
Abortion, Spontaneous |
|
imatinib |
5.87 | 18322153 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.22 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.60 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
pifithrin |
8.22 | 17670903 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
8.22 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
6.49 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.49 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
6.49 | 14692618 |
MESH:D000236 |
Adenoma |
|
2-Acetylaminofluorene |
10.31 | 10737359 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
10.31 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
10.31 | 15688382 |
MESH:D002759 |
Adenoma, Bile Duct |
|
2-Acetylaminofluorene |
5.66 | 6705139 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.04 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.35 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
12.64 | 17306315 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
12.64 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Dichlorodiphenyl Dichloroethylene |
4.46 | 16487989 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.35 | 15955085 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
5.31 | 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
4.31 | 16640825 16563566 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.31 | 16183991 16162502 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.89 | 17688650 |
MESH:D000740 |
Anemia |
|
Iron |
7.95 | 16566752 16434484 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.95 | 11748828 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
4.35 | 16569441 17163184 17162259 17375513 17147795 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
4.51 | 16910769 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.50 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
7.97 | 17497229 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
7.97 | 19015723 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
4.08 | 16604332 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.77 | 16835338 16251483 12569548 18414634 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.13 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
11.05 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
11.05 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
11.05 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.18 | 16292516 |
MESH:D053627 |
Asthenozoospermia |
|
2,5-hexanedione |
6.41 | 10689203 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.24 | 16456186 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
5.11 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
9.97 | 19371607 12928151 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
9.97 | 16632123 16640825 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
9.97 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.14 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.14 | 17352947 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.14 | 18558336 19232924 18985861 19460635 20603192 17688650 18316065 18940202 17507914 18177632 15238991 16609825 18775368 17157402 18396377 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
4.85 | 16640825 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.08 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.90 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
13.58 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.58 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
13.58 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.44 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.30 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.30 | 8888407 |
MESH:D001859 |
Bone Neoplasms |
|
imatinib |
5.01 | 15867366 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.59 | 14991843 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.94 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
8.91 | 18412241 16436596 16357521 15144691 16651633 |
MESH:D001932 |
Brain Neoplasms |
|
SU 6668 |
8.91 | 15739567 |
MESH:D001943 |
Breast Neoplasms |
|
Dichlorodiphenyl Dichloroethylene |
3.53 | 15061365 |
MESH:D001943 |
Breast Neoplasms |
|
Dieldrin |
3.53 | 15770527 11859874 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.53 | 18497071 17289903 17018787 12948864 14630087 19861407 16675129 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
imatinib |
3.53 | 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
3.53 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.53 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
3.53 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.25 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.02 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.12 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.53 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.40 | 15504454 17687452 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.81 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2-Acetylaminofluorene |
15.83 | 3581430 3084413 17761372 6705139 10737359 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
15.83 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
15.83 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
15.83 | 15073043 16217749 15553829 14691202 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
15.83 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
15.83 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
15.83 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
15.83 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.25 | 16675471 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.53 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.82 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
9.94 | 17687452 18922899 15504454 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
9.94 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
9.94 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
9.94 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
3.78 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.18 | 18670907 18850075 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
3.82 | 16640825 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
3.34 | 16604332 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
6.79 | 15738583 19152805 17938729 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.79 | 15458977 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.02 | 18022660 16973168 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.56 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.56 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
14.21 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
14.21 | 16003739 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
14.21 | 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
14.21 | 20056578 19524636 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
5.64 | 17160924 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.25 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.58 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.88 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.63 | 11677210 16105132 17110522 16919318 15861022 17681005 17333356 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.81 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.27 | 12621046 15340226 15668235 8697196 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.27 | 9407595 |
MESH:D003092 |
Colitis |
|
resveratrol |
8.52 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
8.52 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
17-(allylamino)-17-demethoxygeldanamycin |
5.78 | 15993848 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
5.78 | 16640825 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
5.78 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.54 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.54 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Dichlorodiphenyldichloroethane |
8.87 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.87 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.53 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.86 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
6.89 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
imatinib |
6.89 | 18322153 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.89 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
6.89 | 9224671 16925845 14991402 9664655 9211117 17551590 8800419 10589399 9142499 9125849 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
6.89 | 17688650 8888407 16575769 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.02 | 14966744 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.78 | 15213294 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
17-(allylamino)-17-demethoxygeldanamycin |
5.91 | 18854434 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
4.17 | 16640825 16604332 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.50 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
3.25 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
4.25 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.25 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.08 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
8.08 | 16286809 |
MESH:D003967 |
Diarrhea |
|
SU 5416 |
4.97 | 12673719 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
5.51 | 10663392 11421492 11739529 19923254 15619225 11461765 18713872 19739265 14550746 19085960 12540782 12958197 12153990 11287661 19420014 10915739 11743745 17522070 12392966 16109766 11529661 14725611 10774834 12705907 19370779 19416960 16485898 17906064 17562736 16081117 16393943 11834606 19164858 14986274 12594235 18071297 15968718 16227642 2444490 16781746 16177239 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.51 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
5.51 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.75 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.51 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Dichlorodiphenyl Dichloroethylene |
10.17 | 16487989 |
MESH:D004417 |
Dyspnea |
|
SU 5416 |
10.17 | 12649163 12673719 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.74 | 1851702 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
5.64 | 18357618 |
MESH:D004487 |
Edema |
|
imatinib |
9.95 | 19703484 |
MESH:D004487 |
Edema |
|
resveratrol |
9.95 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
9.95 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.79 | 16714409 18230668 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.79 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.05 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
8.05 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.67 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
6.67 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.73 | 9294722 10568697 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.52 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.82 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.57 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.76 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.31 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.96 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.72 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.22 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.00 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.00 | 9664655 16938888 |
MESH:D005221 |
Fatigue |
|
SU 5416 |
6.04 | 12673719 12649163 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
16.34 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
16.34 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Iron |
16.34 | 16640825 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
16.34 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.12 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.54 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.81 | 18558336 8888407 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
imatinib |
5.31 | 17453242 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.52 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
7.52 | 17994277 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.21 | 6392382 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
5.09 | 16604332 16640825 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.94 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.33 | 16983495 |
MESH:D046152 |
Gastrointestinal Stromal Tumors |
marker/mechanism |
|
| |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.59 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.95 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.34 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
6.68 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.68 | 17312396 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
6.72 | 16651633 16357521 18412241 |
MESH:D005910 |
Glioma |
|
SU 6668 |
6.72 | 15739567 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.25 | 10696789 |
MESH:D006261 |
Headache |
|
SU 5416 |
5.71 | 12673719 12649163 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
2.96 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.81 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.93 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.93 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
pifithrin |
4.36 | 14766674 |
MESH:D006390 |
Hemangioendothelioma |
|
2-Acetylaminofluorene |
4.97 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
2-Acetylaminofluorene |
4.10 | 6705139 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
4.24 | 16574947 16604332 16640825 17053826 17236123 17255318 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.03 | 11000095 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
4.87 | 16604332 |
MESH:D006505 |
Hepatitis |
|
Dichlorodiphenyl Dichloroethylene |
4.72 | 16487989 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
5.12 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
4.61 | 17182432 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
7.65 | 16890145 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.65 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.69 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.84 | 16876885 |
MESH:D015658 |
HIV Infections |
|
Iron |
3.49 | 16597321 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.88 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.41 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.53 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.70 | 15340226 16959395 8697196 18606429 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.74 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
6.74 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.70 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.24 | 16778211 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.16 | 17050553 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.72 | 16873680 |
MESH:D006973 |
Hypertension |
|
Arsenic |
4.78 | 11953799 16076760 9931084 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.78 | 18850075 18670907 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.01 | 17488730 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.21 | 16093927 |
MESH:D007006 |
Hypogonadism |
|
Iron |
4.16 | 16640825 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.48 | 16569931 16945680 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
4.75 | 16640825 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
pifithrin |
10.85 | 19475672 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
10.85 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene |
15.59 | 12515675 |
MESH:D007247 |
Infertility, Female |
|
Dieldrin |
15.59 | 10630421 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
15.59 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene |
18.76 | 12515675 |
MESH:D007248 |
Infertility, Male |
|
Dichlorodiphenyl Dichloroethylene |
18.76 | 17192596 12948891 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
18.76 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
18.76 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
18.76 | 16467254 |
MESH:D007249 |
Inflammation |
|
resveratrol |
4.48 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.48 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.20 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.75 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.44 | 17994277 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
4.72 | 17163184 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.92 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.92 | 15992940 17551590 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.65 | 16930632 12749816 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
8.89 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
8.89 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
8.89 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.81 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
6.81 | 17379185 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
9.60 | 12970779 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
9.60 | 15070760 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
9.60 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.49 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.97 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
8.04 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
imatinib |
8.04 | 19208803 15748426 15107311 17301526 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
14.39 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
imatinib |
14.39 | 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
14.39 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
marker/mechanism |
|
| |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
10.99 | 19850784 17050201 16467208 20471514 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
SU 5416 |
10.99 | 12649163 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
10.99 | 17596541 16294345 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
10.99 | 16294345 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Vitamin D |
10.99 | 20368581 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
16.37 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
16.37 | 15213294 15622746 17712046 15748426 19075265 16331271 12018890 16966277 16823087 19225113 9834237 16330433 17107899 12679006 16891316 17869043 19642359 11161223 19035177 17217047 11468182 15336539 16112521 12712474 17649720 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
16.37 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
16.37 | 16891316 17506722 19642359 17217047 19075265 12679006 17649720 19225113 17339181 16140955 19035177 16935935 17294898 19029980 17361223 17301526 9834237 16766008 17368321 15748426 16823087 16331271 16788101 17107899 17712046 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.03 | 16882451 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
5.09 | 16563566 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.39 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Dichlorodiphenyl Dichloroethylene |
7.83 | 12745335 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
7.83 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
3.54 | 16640825 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.63 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
imatinib |
4.63 | 16596278 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.63 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.63 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.75 | 19460945 12587719 19014921 11587558 19784758 16610002 12969438 16611625 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
3.75 | 11134558 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
4.67 | 16737972 17207112 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.94 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2-Acetylaminofluorene |
23.57 | 16273603 11376686 18001218 14678523 10672840 10737359 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
23.57 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
23.57 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Dieldrin |
23.57 | 9539021 8742319 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
23.57 | 16640825 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
23.57 | 19812893 20405173 19073162 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
23.57 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
23.57 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2-Acetylaminofluorene |
8.69 | 6150874 1399818 534488 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
8.69 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
8.69 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.09 | 15213294 |
MESH:D008171 |
Lung Diseases |
marker/mechanism |
|
| 21471107 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.95 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.92 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
2-Acetylaminofluorene |
9.97 | 11376686 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
9.97 | 17306315 17976673 19168569 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
9.97 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
9.97 | 16271038 6695378 16019985 17703301 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
9.97 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
9.97 | 15276417 16712894 17077188 17306315 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
9.97 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
3.70 | 15790496 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.99 | 17088997 |
MESH:D017728 |
Lymphoma, Large-Cell, Anaplastic |
|
17-(allylamino)-17-demethoxygeldanamycin |
6.27 | 17157164 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.60 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
4.72 | 15375218 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.79 | 16640825 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.91 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
8.86 | 16891317 11807958 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
8.86 | 10767621 10838139 18041768 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
8.86 | 11606380 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.14 | 19453300 |
MESH:D034721 |
Mastocytosis, Systemic |
|
PKC412 |
6.75 | 17420286 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.65 | 17453147 |
MESH:D008545 |
Melanoma |
|
resveratrol |
4.77 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.77 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
4.77 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.24 | 19513568 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
5.64 | 17943659 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.09 | 16940565 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.07 | 17112576 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.55 | 17671175 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.95 | 18765137 18803445 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
6.62 | 19549372 19417148 15949261 14977855 11468182 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
6.62 | 17049120 16490592 17164350 17935668 14749477 16267019 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
5.33 | 17086897 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.53 | 17962980 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.72 | 8888407 |
MESH:D009181 |
Mycoses |
|
Iron |
5.12 | 16640825 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.33 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
16.04 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
SU 5416 |
16.04 | 12649163 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
16.04 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
16.04 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
2.89 | 17188708 17125593 16525036 16317513 17015251 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
19.67 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
19.67 | 16604332 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
19.67 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
19.67 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.88 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
7.88 | 16604332 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.42 | 17322642 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.64 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
imatinib |
3.87 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Dieldrin |
10.60 | 8820588 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
10.60 | 11559025 |
MESH:D009369 |
Neoplasms |
|
SU 5416 |
10.60 | 17264769 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
10.60 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
13.47 | 16707424 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
13.47 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
13.47 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
imatinib |
5.12 | 17614352 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.39 | 17289903 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
4.23 | 17178036 |
MESH:D009422 |
Nervous System Diseases |
|
2,5-hexanedione |
5.79 | 12164553 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.46 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.46 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
14.46 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
20.41 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
20.41 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
20.41 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
20.41 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
20.41 | 16359493 8888407 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.07 | 16651423 16003739 17160924 |
MESH:D019636 |
Neurodegenerative Diseases |
|
2,5-hexanedione |
17.98 | 17492505 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
17.98 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
17.98 | 16604332 17296847 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
17.98 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
9.66 | 17056641 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
9.66 | 17929310 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
5.64 | 17160924 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
3.76 | 16640825 |
MESH:D010014 |
Osteolysis |
|
imatinib |
5.40 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Iron |
7.34 | 16648989 16640825 |
MESH:D010024 |
Osteoporosis |
|
Vitamin D |
7.34 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
3.94 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
17.38 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
17.38 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
17.38 | 16624393 19769630 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
17.38 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
17.38 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
17.38 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
5.69 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
5.69 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
4.86 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
4.86 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.37 | 11578682 |
MESH:D010212 |
Papilloma |
|
Iron |
4.15 | 12065085 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.85 | 19927285 |
MESH:D020447 |
Parasomnias |
|
Iron |
5.67 | 17352947 |
MESH:D010300 |
Parkinson Disease |
|
Dieldrin |
5.53 | 16112328 11181820 11445065 16809432 17291500 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
5.53 | 16563566 16640825 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.90 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
3.86 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.65 | 16905509 6392382 15371236 |
MESH:D016116 |
Piebaldism |
marker/mechanism |
|
| |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
5.33 | 16604332 |
MESH:D011041 |
Poisoning |
|
Iron |
3.98 | 16604332 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
9.95 | 16640825 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
9.95 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
imatinib |
4.29 | 12476293 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
4.16 | 16640825 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
20.45 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
20.45 | 11399792 11118676 11896295 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
20.45 | 20603192 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
20.45 | 18220299 18042343 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.59 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.58 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
1.90 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
1.90 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.90 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
1.90 | 17718901 16731767 15767336 17636462 17804756 17675339 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.90 | 16039940 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.59 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
8.24 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
8.24 | 16636307 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
5.67 | 16640825 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.98 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.19 | 12752131 11422049 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.45 | 16723453 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.24 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.10 | 16314181 17058453 15827377 17520802 16317513 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 18990726 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
4.30 | 16930377 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.82 | 16116481 16283617 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
9.82 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.64 | 16646077 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.02 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.52 | 1511512 11738929 11044598 16876388 3137016 15475178 14763951 17978042 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.66 | 18709164 17938729 19834688 17453740 16702368 17548696 17050553 16353154 6392382 16759981 15952646 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
20.34 | 17976673 15504454 17029826 16251483 19538983 17050553 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
20.34 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
20.34 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
20.34 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
20.34 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
20.34 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.60 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
8.68 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
8.68 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.19 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.36 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
imatinib |
3.36 | 15786421 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.36 | 17261132 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.19 | 16321402 |
MESH:D013345 |
Subarachnoid Hemorrhage |
|
pifithrin |
5.71 | 18364113 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
5.11 | 16640825 |
MESH:D013733 |
Testicular Diseases |
|
2,5-hexanedione |
5.98 | 17725299 |
MESH:D013736 |
Testicular Neoplasms |
marker/mechanism |
|
| |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.31 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
8.66 | 15669648 |
MESH:D013927 |
Thrombosis |
|
SU 5416 |
8.66 | 12649163 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
4.82 | 15790496 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.56 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
10.69 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
imatinib |
10.69 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
10.69 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.34 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.93 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.93 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.62 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.89 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Iron |
7.47 | 16597321 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
7.47 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.18 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Acetylaminofluorene |
10.84 | 1399818 15867355 15289314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
10.84 | 17976673 17306315 11144890 19429237 19322015 18640142 15987713 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
10.84 | 12845720 20435036 12973940 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
10.84 | 17306315 16452187 16712894 11723127 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.31 | 8888407 |
MESH:D014570 |
Urologic Diseases |
|
Dichlorodiphenyl Dichloroethylene |
5.39 | 16487989 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.67 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
14.19 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
14.19 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
14.19 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.43 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
8.43 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.26 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
10.71 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
10.71 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.25 | 12125929 |
MESH:D020301 |
Vasospasm, Intracranial |
|
pifithrin |
5.28 | 18364113 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.24 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.97 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.73 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.90 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.68 | 16287080 |